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Acquired immunodeficiency syndrome (AIDS) is a specific group of diseases or conditions which are indicative of severe
immunosuppression related to infection with the human immunodeficiency virus (HIV).
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Through June 1995, nearly half a million (476,899)
persons have been reported with AIDS. The
expanded AIDS surveillance case definition (imple-
mented on January 1, 1993) continues to influence
the pattern of AIDS diagnosis and reporting. In the
first half of 1995, 37,142 AIDS cases were reported.
Although this number exceeds the 23,896 cases
reported in the first half of 1992, before the case defi-
nition was expanded, it is less than the 61,887 and
40,457 cases reported in the first halves of 1993 and
1994, respectively. Trends in reporting of AIDS cases
are expected to continue to stabilize gradually over
the next several reporting periods as the surge in
cases caused by the expanded definition continues to
wane.  
Analysis of the absolute numbers of cases reported
each year, as presented in this report, continues to
provide valuable information on the magnitude of the
epidemic in affected communities. The data provide
an important profile of young (13 to 24 years) men
and women with HIV infection and AIDS, and demon-
strate the need for prevention strategies appropriate
for these age groups (see Tables 7 and 20). They also
profile the characteristics of children with HIV and
AIDS, in whom nearly all recent HIV infections
occurred perinatally, and emphasize that, to prevent
HIV in children, prevention programs need to assist
women in reducing their risk of acquiring HIV infection
by reducing high risk drug-injection or sexual activities
(see Tables 6 and 19). These data will assist states in
monitoring the impact of current recommendations to
reduce HIV transmission to children through counsel-
ing, voluntary testing, and prenatal care services for
women. 
The expansion of the case definition artifactually
distorted the AIDS epidemic curve. Fluctuation in the
number of reported cases in recent years has compli-
cated the interpretation of trends in the absolute num-
ber of reported cases. However, comparing propor-
tions and relative rates over time permits trends to be
monitored. For example, in the two most recent 12-
month periods, about 10 percent of persons with AIDS
were residents of small metropolitan areas (50,000 to
500,000 population), and about 6 percent were resi-
dents of non-metropolitan areas (see Table 2). These
percentages are consistent with those reported for
1992 (10 percent and 6 percent, respectively), before
the case definition was expanded. They not only
reflect the emergence of AIDS outside large metropol-
itan areas (500,000 or more population), but also illus-
trate that the epidemic remains disproportionately
concentrated in large metropolitan areas, where AIDS
incidence rates are consistently 2 to 3 times higher
than in small metropolitan areas, and about 5 times
higher than in non-metropolitan areas.
To monitor trends in the incidence of AIDS-defining
opportunistic illnesses (AIDS-OIs), CDC is using ana-
lytic methods that adjust for the case definition expan-
sion by using comparable definitions over time. The
estimated number of persons with AIDS-OIs diag-
nosed in 1994 (64,300) increased approximately 6
percent over the estimated number in 1993 (see Table
13).  In addition, previously reported trends continued:
the South and the Northeast accounted for the major-
ity of the estimated number of persons with AIDS-OIs,
and blacks and Hispanics accounted for a growing
proportion of persons with AIDS-OIs (see Table 14).
Although men who have sex with men accounted for
the largest proportion of AIDS-OIs, the rate of growth
has slowed; persons infected through injecting drug-
use and their heterosexual partners accounted for an
increasing proportion of persons with AIDS-OIs (see
Table 15). 
AIDS surveillance data can detect recent shifts in
the epidemic: because AIDS develops in a substantial
number of HIV-infected persons within a year or two
of infection, their characteristics are soon reflected in
the surveillance data. For example, emerging trends
among women, black and Hispanic minorities, per-
sons in moderate- and small-sized metropolitan sta-
tistical areas and in the rural South, persons infected
through heterosexual contact, minority homosexual/
bisexual men, and young men who have sex with men
have all been detected through AIDS surveillance. In
addition, timely data from 25 states on characteristics
of adults/adolescents with HIV infection (not AIDS)
have documented the impact of the epidemic among
sexually active and drug-using adolescents at early
stages of HIV disease and have highlighted the need
for appropriate prevention interventions in these pop-
ulations (see Table 20).  
National population-based HIV/AIDS surveillance
data can be used to guide allocation of resources for
HIV/AIDS prevention and control. State and local
health departments provide surveillance information
to assist prevention planning in local communities.
Together with data from seroprevalence surveys,
behavioral surveys, and vital statistics, HIV/AIDS sur-
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veillance data can assist communities in developing
HIV needs assessments, health care planning, and
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Table 1. AIDS cases and annual rates per 100,000 population, by state, reported July 1993




 and cumulative totals, by state





June 1995 Cumulative totals




< 13 years old Total 
 
Alabama 556 13.3 566 13.4 3,266 52 3,318
Alaska 74 12.4 79 13.0 301 4 305
Arizona 645 16.4 559 13.7 4,047 19 4,066
Arkansas 289 11.9 288 11.7 1,725 25 1,750
California 14,388 46.1 10,989 35.0 82,937 460 83,397
Colorado 880 24.7 718 19.6 4,914 26 4,940
Connecticut 1,303 39.8 1,066 32.5 6,321 140 6,461
Delaware 263 37.7 313 44.3 1,338 11 1,349
District of Columbia 1,575 272.0 1,220 214.0 7,593 115 7,708
Florida 7,750 56.5 9,377 67.2 47,076 1,062 48,138
Georgia 2,240 32.5 2,284 32.4 13,203 140 13,343
Hawaii 318 27.3 263 22.3 1,667 13 1,680
Idaho 55 5.0 57 5.0 303 2 305
Illinois 2,748 23.5 2,785 23.7 15,306 171 15,477
Indiana 723 12.7 524 9.1 3,538 28 3,566
Iowa 99 3.5 145 5.1 794 8 802
Kansas 266 10.5 284 11.1 1,508 9 1,517
Kentucky 300 7.9 311 8.1 1,671 13 1,684
Louisiana 1,226 28.6 1,124 26.0 6,995 92 7,087
Maine 137 11.1 139 11.2 644 6 650
Maryland 2,235 45.1 2,951 58.9 11,613 224 11,837
Massachusetts 2,024 33.6 1,396 23.1 9,874 163 10,037
Michigan 1,080 11.4 1,071 11.3 6,728 75 6,803
Minnesota 392 8.7 413 9.0 2,529 17 2,546
Mississippi 411 15.6 414 15.5 2,156 37 2,193
Missouri 815 15.6 696 13.2 5,934 41 5,975
Montana 30 3.6 24 2.8 176 2 178
Nebraska 106 6.6 111 6.8 639 7 646
Nevada 444 32.1 413 28.3 2,368 20 2,388
New Hampshire 90 8.0 116 10.2 560 7 567
New Jersey 5,220 66.4 4,764 60.3 26,562 600 27,162
New Mexico 163 10.1 228 13.8 1,175 4 1,179
New York 15,122 83.3 12,578 69.2 86,318 1,704 88,022
North Carolina 1,295 18.6 1,015 14.4 5,828 81 5,909
North Dakota 27 4.2 7 1.1 64 - 64
Ohio 1,359 12.3 1,188 10.7 7,044 82 7,126
Oklahoma 346 10.7 266 8.2 2,301 17 2,318
Oregon 577 19.0 506 16.4 3,151 13 3,164
Pennsylvania 2,815 23.4 2,678 22.2 13,822 207 14,029
Rhode Island 277 27.7 291 29.2 1,324 15 1,339
South Carolina 1,170 32.2 995 27.2 4,817 58 4,875
South Dakota 17 2.4 20 2.8 91 4 95
Tennessee 851 16.7 883 17.1 4,222 37 4,259
Texas 5,841 32.4 5,153 28.0 32,732 270 33,002
Utah 136 7.3 153 8.0 1,074 20 1,094
Vermont 81 14.1 32 5.5 243 3 246
Virginia 1,369 21.1 1,150 17.6 6,829 125 6,954
Washington 1,182 22.5 933 17.5 6,394 22 6,416
West Virginia 78 4.3 114 6.3 536 6 542
Wisconsin 401 7.9 366 7.2 2,323 23 2,346
Wyoming 20 4.3 13 2.7 121 - 121
 
Subtotal 81,809 31.7 74,029 28.4 454,695 6,280 460,975
 
Guam 1 0.7 - - 14 - 14
Pacific Islands, U.S. - - - - 2 - 2
Puerto Rico 2,616 72.5 2,582 71.0 14,937 320 15,257










See Technical Notes for a discussion of the impact of the 1993 AIDS surveillance case definition for adults and adolescents (implemented January 1,




Totals include 408 persons whose state of residence is unknown.
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Table 2. AIDS cases and annual rates per 100,000 population, by metropolitan area with





 and cumulative totals, by area and age group, through 





June 1995 Cumulative totals 




<13 years old Total 
 
Akron, Ohio 62 9.2 47 6.9 311 - 311
Albany-Schenectady, N.Y. 146 16.7 169 19.3 938 20 958
Albuquerque, N.Mex. 79 12.5 108 16.7 649 2 651
Allentown, Pa. 98 16.1 94 15.4 450 5 455
Ann Arbor, Mich. 38 7.5 36 7.0 246 5 251
Atlanta, Ga. 1,499 46.4 1,600 48.0 9,537 74 9,611
Austin, Tex. 528 56.6 388 40.3 2,486 16 2,502
Bakersfield, Calif. 129 21.5 76 12.5 516 3 519
Baltimore, Md. 1,478 60.5 2,058 83.7 7,590 161 7,751
Baton Rouge, La. 175 31.6 168 30.1 785 13 798
Bergen-Passaic, N.J. 788 60.7 614 47.1 3,488 59 3,547
Birmingham, Ala. 193 22.3 158 18.1 1,020 14 1,034
Boston, Mass. 1,754 30.8 1,217 21.2 8,777 143 8,920
Buffalo, N.Y. 104 8.7 107 9.0 854 10 864
Charleston, S.C. 187 35.6 152 29.1 913 10 923
Charlotte, N.C. 260 21.1 220 17.5 1,191 12 1,203
Chicago, Ill. 2,381 31.3 2,479 32.3 13,406 152 13,558
Cincinnati, Ohio 225 14.3 220 13.9 1,151 12 1,163
Cleveland, Ohio 343 15.4 474 21.3 2,101 32 2,133
Columbus, Ohio 360 25.5 191 13.4 1,504 8 1,512
Dallas, Tex. 1,171 41.2 1,422 49.1 8,124 34 8,158
Dayton, Ohio 106 11.1 52 5.4 615 8 623
Denver, Colo. 676 38.4 569 31.7 4,000 18 4,018
Detroit, Mich. 659 15.3 778 18.1 4,690 55 4,745
El Paso, Tex. 82 12.7 116 17.4 482 2 484
Fort Lauderdale, Fla. 1,130 83.7 1,609 116.3 7,466 173 7,639
Fort Worth, Tex. 321 22.4 550 37.6 2,092 21 2,113
Fresno, Calif. 155 18.8 123 14.7 729 8 737
Gary, Ind. 74 12.0 97 15.6 401 2 403
Grand Rapids, Mich. 85 8.7 69 7.0 463 3 466
Greensboro, N.C. 169 15.5 206 18.6 976 12 988
Greenville, S.C. 232 26.9 143 16.4 823 2 825
Harrisburg, Pa. 106 17.5 89 14.6 483 5 488
Hartford, Conn. 587 52.4 393 35.2 2,158 36 2,194
Honolulu, Hawaii 224 25.9 191 21.8 1,237 10 1,247
Houston, Tex. 2,082 58.0 1,337 36.6 11,904 104 12,008
Indianapolis, Ind. 413 28.6 216 14.8 1,721 11 1,732
Jacksonville, Fla. 347 36.1 478 49.2 2,738 61 2,799
Jersey City, N.J. 777 140.6 887 160.6 4,321 99 4,420
Kansas City, Mo. 352 21.6 304 18.5 2,770 11 2,781
Knoxville, Tenn. 106 17.1 89 14.1 401 4 405
Las Vegas, Nev. 343 33.9 337 31.3 1,850 19 1,869
Little Rock, Ark. 98 18.4 96 17.9 643 9 652
Los Angeles, Calif. 4,786 52.4 3,979 43.5 28,850 188 29,038
Louisville, Ky. 130 13.3 142 14.5 737 8 745
Memphis, Tenn. 308 29.6 334 31.6 1,521 12 1,533
Miami, Fla. 2,924 146.0 2,980 147.2 14,835 373 15,208
Middlesex, N.J. 361 34.2 392 36.7 2,163 60 2,223
Milwaukee, Wis. 218 15.0 212 14.6 1,263 14 1,277
Minneapolis-Saint Paul, Minn. 334 12.6 369 13.7 2,235 14 2,249
Mobile, Ala. 86 17.0 104 20.3 665 9 674
Monmouth-Ocean City, N.J. 335 32.8 351 33.9 1,865 48 1,913
Nashville, Tenn. 241 23.1 289 27.0 1,310 14 1,324
Nassau-Suffolk, N.Y. 573 21.7 552 20.8 4,119 75 4,194
New Haven, Conn. 612 37.6 580 35.7 3,650 98 3,748
New Orleans, La. 701 53.8 612 46.8 4,106 50 4,156
New York, N.Y. 13,431 156.7 10,780 125.6 74,312 1,547 75,859
Newark, N.J. 2,136 110.8 1,741 90.0 10,621 262 10,883
Norfolk, Va. 371 24.5 392 25.6 1,658 43 1,701
Oakland, Calif. 968 44.6 745 34.1 5,615 32 5,647
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Oklahoma City, Okla. 141 14.2 100 9.9 1,055 2 1,057
Omaha, Nebr. 70 10.6 77 11.6 454 2 456
Orange County, Calif. 569 22.6 543 21.4 3,775 24 3,799
Orlando, Fla. 430 32.2 747 54.9 3,320 57 3,377
Philadelphia, Pa. 2,258 45.7 2,039 41.2 10,699 173 10,872
Phoenix, Ariz. 431 18.0 393 15.9 2,904 11 2,915
Pittsburgh, Pa. 269 11.2 329 13.7 1,599 10 1,609
Portland, Oreg. 443 26.9 398 23.7 2,650 8 2,658
Providence, R.I. 261 28.6 273 29.9 1,242 14 1,256
Raleigh-Durham, N.C. 266 28.4 186 19.3 1,205 19 1,224
Richmond, Va. 258 28.5 227 24.8 1,430 19 1,449
Riverside-San Bernardino, Calif. 976 34.0 830 28.6 4,252 41 4,293
Rochester, N.Y. 193 17.7 218 20.0 1,124 8 1,132
Sacramento, Calif. 434 30.3 356 24.7 2,142 21 2,163
Saint Louis, Mo. 442 17.5 382 15.1 2,927 26 2,953
Salt Lake City, Utah 119 10.3 126 10.7 942 14 956
San Antonio, Tex. 636 45.2 384 26.7 2,438 22 2,460
San Diego, Calif. 1,221 46.7 952 36.2 6,758 39 6,797
San Francisco, Calif. 3,433 209.6 2,163 131.4 21,795 33 21,828
San Jose, Calif. 479 31.0 291 18.7 2,146 11 2,157
San Juan, P.R. 1,553 82.0 1,542 80.6 9,351 209 9,560
Sarasota, Fla. 183 35.8 170 32.8 876 18 894
Scranton, Pa. 36 5.6 49 7.7 269 3 272
Seattle, Wash. 770 35.7 658 30.2 4,673 13 4,686
Springfield, Mass. 265 44.3 185 31.1 967 19 986
Stockton, Calif. 135 26.4 48 9.3 450 12 462
Syracuse, N.Y. 96 12.7 120 15.9 697 7 704
Tacoma, Wash. 127 20.1 82 12.8 511 7 518
Tampa-Saint Petersburg, Fla. 778 36.4 830 38.5 5,116 73 5,189
Toledo, Ohio 52 8.5 47 7.7 351 7 358
Tucson, Ariz. 165 23.2 118 16.1 859 6 865
Tulsa, Okla. 117 15.8 81 10.9 702 6 708
Ventura, Calif. 79 11.4 72 10.2 509 2 511
Washington, D.C. 2,742 62.1 2,160 48.3 13,426 200 13,626
West Palm Beach, Fla. 586 62.9 864 90.5 4,203 152 4,355
Wichita, Kans. 72 14.3 98 19.3 428 2 430
Wilmington, Del. 219 41.0 256 47.5 1,043 9 1,052
Youngstown, Ohio 33 5.5 35 5.8 209 - 209
 
Metropolitan areas with
500,000 or more population 70,974 44.0 63,710 39.1 398,022 5,604 403,626
 
Central counties 69,653 47.1 62,408 41.9 390,951 5,501 396,452
Outlying counties 1,321 9.6 1,302 9.3 7,071 103 7,174
 
Metropolitan areas with 
50,000 to 500,000 population 8,400 17.7 7,905 16.5 45,419 623 46,042
 
Central counties 7,891 18.7 7,402 17.4 42,662 570 43,232
Outlying counties 509 9.9 503 9.6 2,757 53 2,810
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Totals include 2,122 persons whose area of residence is unknown.
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June 1995 Cumulative totals 




<13 years old Total 
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Table 3. AIDS cases by age group, exposure category, and sex, reported July 1993 through




 and cumulative totals, by age group and
























exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Men who have sex with men 38,504 (55) 32,448 (52) – – – – 38,504 (46) 32,448 (43) 244,235 (52)
Injecting drug use 17,468 (25) 14,728 (24) 6,343 (45) 5,421 (39) 23,811 (28) 20,149 (27) 118,694 (25)
Men who have sex with men 
and inject drugs 4,765 ( 7) 3,609 ( 6) – – – – 4,765 ( 6) 3,609 ( 5) 31,024 ( 7)
Hemophilia/coagulation disorder 583 ( 1) 430 ( 1) 19 ( 0) 23 ( 0) 602 ( 1) 453 ( 1) 3,872 ( 1)
Heterosexual contact: 2,914 ( 4) 2,974 ( 5) 5,685 (40) 5,204 (38) 8,600 (10) 8,178 (11) 35,683 ( 8)
 
Sex with injecting drug user 1,004 903 2,299 1,893 3,303 2,796 17,118
Sex with bisexual male – – 441 346 441 346 1,999
Sex with person with hemophilia 3 6 61 57 64 63 299
Sex with transfusion recipient 
with HIV infection 61 65 82 57 143 122 692
Sex with HIV-infected person, 
risk not specified 1,846 2,000 2,802 2,851 4,649 4,851 15,575
 
Receipt of blood transfusion, 




468 ( 1) 382 ( 1) 361 ( 3) 305 ( 2) 829 ( 1) 687 ( 1) 7,128 ( 2)




4,745 ( 7) 7,414 (12) 1,734 (12) 2,885 (21) 6,479 ( 8) 10,301 (14) 29,652 ( 6)
Adult/adolescent subtotal 69,447 (100) 61,985 (100) 14,142 (100) 13,838 (100) 83,590 (100) 75,825 (100) 470,288 (100)
 
Pediatric (<13 years old) 
exposure category
 
Hemophilia/coagulation disorder 16 ( 3) 11 ( 2) 1 ( 0) – – 17 ( 2) 11 ( 1) 226 ( 3)




443 (92) 419 (88) 478 (95) 462 (92) 921 (93) 881 (90) 5,925 (90)
 
Injecting drug use 153 120 160 136 313 256 2,471
Sex with injecting drug user 74 70 71 69 145 139 1,107
Sex with bisexual male 5 10 5 10 10 20 120
Sex with person with hemophilia 1 1 – 1 1 2 24
Sex with transfusion recipient
 with HIV infection 3 1 1 3 4 4 27
Sex with HIV-infected person,
risk not specified 70 91 85 89 155 180 676
Receipt of blood transfusion,
 blood components, or tissue 12 2 10 5 22 7 140
Has HIV infection, risk 
not specified 125 124 146 149 271 273 1,360
 
Receipt of blood transfusion,
blood components, or tissue 17 ( 4) 23 ( 5) 13 ( 3) 14 ( 3) 30 ( 3) 37 ( 4) 359 ( 5)




6 ( 1) 24 ( 5) 13 ( 3) 24 ( 5) 19 ( 2) 48 ( 5) 101 ( 2)
Pediatric subtotal 482 (100) 477 (100) 505 (100) 500 (100) 987 (100) 977 (100) 6,611 (100)
 




See Technical Notes for a discussion of the impact of the 1993 AIDS surveillance case definition for adults and adolescents (implemented January 1, 1993) on
















Thirty-three adults/adolescents and 2 children developed AIDS after receiving blood screened negative for HIV antibody. Ten additional adults developed AIDS
after receiving tissue, organs, or artificial insemination from HIV-infected donors. Three of the 10 received tissue, organs, or artificial insemination from a donor
who was negative for HIV antibody at the time of donation. See 
 






See Table 11 and Figure 6 for a discussion of the "other" exposure category. "Other" also includes 25 persons who acquired HIV infection perinatally but were
diagnosed with AIDS after age 13. These 25 persons are tabulated under the adult/adolescent, not pediatric, exposure category.
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Table 4. Male adult/adolescent AIDS cases by exposure category and race/ethnicity, 
reported July 1994 through June 1995, and cumulative totals, through June 1995,
 United States
 













Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Men who have sex with men 19,837 (71) 162,549 (77) 7,543 (34) 48,167 (40) 4,568 (40) 30,303 (45)
Injecting drug use 2,943 (11) 17,915 ( 8) 7,652 (35) 44,054 (36) 4,049 (36) 25,742 (38)
Men who have sex with men 
and inject drugs 1,840 ( 7) 16,651 ( 8) 1,219 ( 6) 9,388 ( 8) 498 ( 4) 4,691 ( 7)
Hemophilia/coagulation disorder 323 ( 1) 3,008 ( 1) 54 ( 0) 365 ( 0) 41 ( 0) 304 ( 0)
Heterosexual contact: 584 ( 2) 2,663 ( 1) 1,667 ( 8) 6,653 ( 5) 700 ( 6) 2,647 ( 4)
 
Sex with injecting drug user 185 1,164 519 3,032 193 931
Sex with person with hemophilia 4 16 2 4 – 6
Sex with transfusion recipient 
with HIV infection 30 110 18 90 16 66
Sex with HIV-infected person, 
risk not specified 365 1,373 1,128 3,527 491 1,644
 
Receipt of blood transfusion,
blood components, or tissue 208 ( 1) 2,797 ( 1) 119 ( 1) 829 ( 1) 43 ( 0) 450 ( 1)




2,127 ( 8) 6,273 ( 3) 3,744 (17) 11,561 (10) 1,426 (13) 3,914 ( 6)
 
Total 27,862 (100) 211,856 (100) 21,998 (100) 121,017 (100) 11,325 (100) 68,051 (100)
















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Men who have sex with men 347 (72) 2,263 (78) 106 (54) 618 (61) 32,448 (52) 244,235 (60)
Injecting drug use 26 ( 5) 132 ( 5) 39 (20) 135 (13) 14,728 (24) 88,121 (22)
Men who have sex with men 
and inject drugs 16 ( 3) 92 ( 3) 33 (17) 175 (17) 3,609 ( 6) 31,024 ( 8)
Hemophilia/coagulation disorder 8 ( 2) 46 ( 2) 2 ( 1) 24 ( 2) 430 ( 1) 3,755 ( 1)
Heterosexual contact: 16 ( 3) 57 ( 2) 3 ( 2) 17 ( 2) 2,974 ( 5) 12,049 ( 3)
 
Sex with injecting drug user 3 17 2 8 903 5,154
Sex with person with hemophilia – – – – 6 26
Sex with transfusion recipient 
with HIV infection 1 4 – 1 65 272
Sex with HIV-infected person, 
risk not specified 12 36 1 8 2,000 6,597
 
Receipt of blood transfusion, 
blood components, or tissue 9 ( 2) 89 ( 3) 2 ( 1) 6 ( 1) 382 ( 1) 4,183 ( 1)
Risk not reported or identified 61 (13) 223 ( 8) 13 ( 7) 35 ( 3) 7,414 (12) 22,095 ( 5)
 








Includes 626 men whose race/ethnicity is unknown.
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Table 5. Female adult/adolescent AIDS cases by exposure category and race/ethnicity, 
reported July 1994 through June 1995, and cumulative totals, through June 1995,
United States
 













Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Injecting drug use 1,238 (40) 6,739 (43) 3,119 (40) 17,601 (50) 1,030 (37) 6,043 (45)
Hemophilia/coagulation disorder 15 ( 0) 78 ( 1) 5 ( 0) 25 ( 0) 3 ( 0) 13 ( 0)
Heterosexual contact: 1,167 (38) 5,786 (37) 2,664 (34) 11,767 (33) 1,330 (47) 5,846 (44)
 
Sex with injecting drug user 455 2,639 892 5,891 531 3,341
Sex with bisexual male 142 934 127 717 68 297
Sex with person with hemophilia 41 211 10 37 5 20
Sex with transfusion recipient 
with HIV infection 26 229 20 105 8 69
Sex with HIV-infected person, 
risk not specified 503 1,773 1,615 5,017 718 2,119
 
Receipt of blood transfusion, 
blood components, or tissue 117 ( 4) 1,596 (10) 125 ( 2) 834 ( 2) 55 ( 2) 436 ( 3)




535 (17) 1,371 ( 9) 1,934 (25) 5,145 (15) 391 (14) 955 ( 7)
 
Total 3,072 (100) 15,570 (100) 7,847 (100) 35,372 (100) 2,809 (100) 13,293 (100)
















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Injecting drug use 13 (22) 59 (18) 15 (47) 84 (49) 5,421 (39) 30,573 (47)
Hemophilia/coagulation disorder – – 1 ( 0) – – – – 23 ( 0) 117 ( 0)
Heterosexual contact: 24 (40) 144 (44) 14 (44) 63 (36) 5,204 (38) 23,633 (36)
 
Sex with injecting drug user 7 43 7 36 1,893 11,964
Sex with bisexual male 5 41 4 8 346 1,999
Sex with person with hemophilia 1 3 – 2 57 273
Sex with transfusion recipient 
with HIV infection 2 15 – – 57 420
Sex with HIV-infected person, 
risk not specified 9 42 3 17 2,851 8,977
 
Receipt of blood transfusion, 
blood components, or tissue 8 (13) 68 (21) – – 10 ( 6) 305 ( 2) 2,945 ( 5)
Risk not reported or identified 15 (25) 53 (16) 3 ( 9) 16 ( 9) 2,885 (21) 7,554 (12)
 








Includes 89 women whose race/ethnicity is unknown.
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Table 6. Pediatric AIDS cases by exposure category and race/ethnicity, reported July 1994
through June 1995, and cumulative totals, through June 1995, United States
 













Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Hemophilia/coagulation disorder 9 ( 6) 156 (13) 1 ( 0) 32 ( 1) 1 ( 0) 34 ( 2)
Mother with/at risk for HIV infection: 115 (80) 868 (71) 528 (92) 3,578 (95) 228 (92) 1,424 (91)
 
Injecting drug use 32 373 149 1,470 73 609
Sex with injecting drug user 20 162 70 541 48 395
Sex with bisexual male 5 44 8 41 7 33
Sex with person with hemophilia 1 15 – 5 1 4
Sex with transfusion recipient 
with HIV infection 1 10 1 9 2 8
Sex with HIV-infected person, 
risk not specified 24 87 111 440 42 138
Receipt of blood transfusion, 
blood components, or tissue 1 39 4 73 2 27
Has HIV infection, risk 
not specified 31 138 185 999 53 210
 
Receipt of blood transfusion, 
blood components, or tissue 16 (11) 178 (15) 8 ( 1) 80 ( 2) 12 ( 5) 91 ( 6)




4 ( 3) 14 ( 1) 36 ( 6) 68 ( 2) 6 ( 2) 17 ( 1)
 
Total 144 (100) 1,216 (100) 573 (100) 3,758 (100) 247 (100) 1,566 (100)
















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Hemophilia/coagulation disorder – – 3 ( 8) – – 1 ( 5) 11 ( 1) 226 ( 3)
Mother with/at risk for HIV infection: 5 (63) 24 (63) 2 (100) 18 (95) 881 (90) 5,925 (90)
 
Injecting drug use – 4 1 9 256 2,471
Sex with injecting drug user 1 3 – 4 139 1,107
Sex with bisexual male – 2 – – 20 120
Sex with person with hemophilia – – – – 2 24
Sex with transfusion recipient 
with HIV infection – – – – 4 27
Sex with HIV-infected person, 
risk not specified 2 6 – 1 180 676
Receipt of blood transfusion, 
blood components, or tissue – 1 – – 7 140
Has HIV infection, risk 
not specified 2 8 1 4 273 1,360
 
Receipt of blood transfusion, 
blood components, or tissue 1 (13) 9 (24) – – – – 37 ( 4) 359 ( 5)
Risk not reported or identified 2 (25) 2 ( 5) – – – – 48 ( 5) 101 ( 2)
 








Includes 14 children whose race/ethnicity is unknown.
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Table 7. AIDS cases in adolescents and adults under age 25, by sex and exposure category, 





cumulative totals through June 1995, United States
 













Male exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Men who have sex with men 75 (29) 82 (32) 471 (33) 1,250 (60) 1,029 (60) 8,613 (63)
Injecting drug use 15 ( 6) 16 ( 6) 92 ( 6) 275 (13) 207 (12) 1,727 (13)
Men who have sex with men 
and inject drugs 10 ( 4) 10 ( 4) 68 ( 5) 178 ( 9) 112 ( 7) 1,486 (11)
Hemophilia/coagulation disorder 112 (43) 89 (35) 613 (43) 85 ( 4) 55 ( 3) 501 ( 4)
Heterosexual contact: 10 ( 4) 10 ( 4) 36 ( 3) 95 ( 5) 108 ( 6) 456 ( 3)
 
Sex with injecting drug user 3 1 13 26 37 196
Sex with person with hemophilia – 1 1 – – 1
Sex with transfusion recipient 
with HIV infection – – – 2 2 11
Sex with HIV-infected person, 
risk not specified 7 8 22 67 69 248
 
Receipt of blood transfusion,
blood components, or tissue 15 ( 6) 11 ( 4) 60 ( 4) 17 ( 1) 10 ( 1) 99 ( 1)




21 ( 8) 39 (15) 97 ( 7) 171 ( 8) 200 (12) 717 ( 5)
Male subtotal 258 (100) 257 (100) 1,437 (100) 2,071 (100) 1,721 (100) 13,599 (100)
 
Female exposure category 
 
Injecting drug use 18 (11) 14 ( 7) 122 (16) 223 (27) 183 (22) 1,351 (33)
Hemophilia/coagulation disorder 2 ( 1) 3 ( 2) 9 ( 1) 2 ( 0) 2 ( 0) 12 ( 0)
Heterosexual contact: 93 (55) 89 (48) 397 (53) 455 (54) 423 (51) 2,093 (50)
 
Sex with injecting drug user 32 27 186 189 129 1,058
Sex with bisexual male 5 6 22 31 23 165
Sex with person with hemophilia 1 3 10 13 6 41
Sex with transfusion recipient 
with HIV infection – – 1 2 3 12
Sex with HIV-infected person, 
risk not specified 55 53 178 220 262 817
 
Receipt of blood transfusion, 
blood components, or tissue 7 ( 4) 13 ( 7) 57 ( 8) 12 ( 1) 10 ( 1) 98 ( 2)
Risk not reported or identified 49 (29) 68 (36) 162 (22) 149 (18) 209 (25) 592 (14)
Female subtotal 169 (100) 187 (100) 747 (100) 841 (100) 827 (100) 4,146 (100)
 




See Technical Notes for a discussion of the impact of the 1993 AIDS surveillance case definition for adults and adolescents (implemented January 1,
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Age at diagnosis (years) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Under 5 401 ( 0) 1,593 ( 1) 630 ( 1) 15 ( 1) 9 ( 1) 2,651 ( 1)
5-12 288 ( 0) 270 ( 0) 193 ( 0) 8 ( 0) 1 ( 0) 761 ( 0)
13-19 649 ( 0) 468 ( 0) 288 ( 0) 18 ( 1) 13 ( 1) 1,437 ( 0)
20-24 6,054 ( 3) 4,641 ( 4) 2,735 ( 4) 99 ( 3) 48 ( 5) 13,599 ( 3)
25-29 29,889 (14) 16,854 (14) 10,851 (16) 384 (13) 210 (21) 58,268 (14)
30-34 49,941 (23) 27,096 (22) 16,750 (24) 646 (22) 272 (27) 94,836 (23)
35-39 47,371 (22) 28,321 (23) 15,311 (22) 630 (22) 199 (20) 91,986 (22)
40-44 34,274 (16) 20,518 (17) 10,332 (15) 509 (17) 142 (14) 65,883 (16)
45-49 20,271 (10) 10,877 ( 9) 5,608 ( 8) 281 (10) 63 ( 6) 37,156 ( 9)
50-54 10,900 ( 5) 5,863 ( 5) 2,923 ( 4) 154 ( 5) 30 ( 3) 19,899 ( 5)
55-59 6,082 ( 3) 3,236 ( 3) 1,677 ( 2) 90 ( 3) 15 ( 1) 11,128 ( 3)
60-64 3,514 ( 2) 1,746 ( 1) 908 ( 1) 42 ( 1) 11 ( 1) 6,230 ( 2)
65 or older 2,911 ( 1) 1,397 ( 1) 668 ( 1) 49 ( 2) 7 ( 1) 5,040 ( 1)
Male subtotal 212,545 (100) 122,880 (100) 68,874 (100) 2,925 (100) 1,020 (100) 408,874 (100)
 
Female
Age at diagnosis (years)
 
Under 5 406 ( 3) 1,606 ( 4) 596 ( 4) 9 ( 3) 9 ( 5) 2,634 ( 4)
5-12 121 ( 1) 289 ( 1) 147 ( 1) 6 ( 2) – – 565 ( 1)
13-19 140 ( 1) 482 ( 1) 119 ( 1) 4 ( 1) 1 ( 1) 747 ( 1)
20-24 980 ( 6) 2,217 ( 6) 910 ( 6) 16 ( 5) 18 (10) 4,146 ( 6)
25-29 2,825 (18) 5,885 (16) 2,488 (18) 36 (11) 36 (20) 11,280 (17)
30-34 3,695 (23) 8,692 (23) 3,412 (24) 70 (21) 44 (24) 15,936 (23)
35-39 3,043 (19) 8,140 (22) 2,766 (20) 61 (18) 35 (19) 14,075 (21)
40-44 1,850 (11) 5,085 (14) 1,663 (12) 50 (15) 19 (10) 8,676 (13)
45-49 953 ( 6) 2,208 ( 6) 852 ( 6) 28 ( 8) 8 ( 4) 4,054 ( 6)
50-54 565 ( 4) 1,166 ( 3) 479 ( 3) 16 ( 5) 4 ( 2) 2,233 ( 3)
55-59 445 ( 3) 660 ( 2) 303 ( 2) 10 ( 3) 4 ( 2) 1,424 ( 2)
60-64 326 ( 2) 422 ( 1) 151 ( 1) 16 ( 5) 3 ( 2) 918 ( 1)
65 or older 748 ( 5) 415 ( 1) 150 ( 1) 18 ( 5) 1 ( 1) 1,333 ( 2)
Female subtotal 16,097 (100) 37,267 (100) 14,036 (100) 340 (100) 182 (100) 68,021 (100)
Total2 228,644 160,148 82,910 3,265 1,202 476,899
1Includes 630 males, 99 females, and 1 person with unknown sex whose race/ethnicity is unknown.
2Includes 4 persons whose sex is unknown.
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Table 9. AIDS cases, case-fatality rates,1 and deaths, by half-year and age group, through
June 1995, United States














Before 1981 86 90.7 30 8 75.0 1
1981 Jan.-June 104 90.4 37 10 80.0 2
July-Dec. 203 92.1 83 6 83.3 6
1982 Jan.-June 428 93.2 151 15 93.3 10
July-Dec. 725 91.6 295 16 87.5 4
1983 Jan.-June 1,343 94.2 525 32 100.0 14
July-Dec. 1,700 94.2 945 44 90.9 16
1984 Jan.-June 2,667 93.6 1,423 52 88.5 26
July-Dec. 3,494 93.7 2,015 63 87.3 24
1985 Jan.-June 5,120 92.7 2,869 108 81.5 47
July-Dec. 6,529 93.1 3,973 137 85.4 72
1986 Jan.-June 8,647 92.1 5,185 143 83.2 68
July-Dec. 10,210 92.3 6,696 195 77.9 97
1987 Jan.-June 13,476 91.1 7,798 228 78.1 121
July-Dec. 14,860 89.4 8,233 269 73.6 171
1988 Jan.-June 17,283 87.5 9,671 262 68.3 137
July-Dec. 17,769 87.3 11,032 348 65.5 179
1989 Jan.-June 20,799 84.1 12,694 368 64.4 173
July-Dec. 21,131 82.8 14,592 345 67.5 194
1990 Jan.-June 23,901 80.0 14,995 386 60.6 193
July-Dec. 23,403 77.7 15,952 402 54.0 199
1991 Jan.-June 27,836 73.7 16,993 400 52.0 174
July-Dec. 29,924 69.3 18,861 389 48.1 218
1992 Jan.-June 36,048 61.3 19,247 473 44.4 190
July-Dec. 38,962 54.4 20,416 425 47.3 219
1993 Jan.-June 40,147 41.3 20,571 413 37.8 244
July-Dec. 32,818 34.0 21,503 396 36.9 254
1994 Jan.-June 32,090 24.2 22,091 345 26.7 271
July-Dec. 25,577 15.8 21,475 243 20.6 215
1995 Jan.-June 13,008 7.8 11,112 90 8.9 112
Total2 470,288 62.1 291,815 6,611 55.3 3,658
1Case-fatality rates are calculated for each half-year by date of diagnosis. Each 6-month case-fatality rate is the number of deaths ever reported
among cases diagnosed in that period (regardless of the year of death), divided by the number of total cases diagnosed in that period, multiplied by
100. For example, during the interval January through June 1982, AIDS was diagnosed in 428 adults/adolescents. Through June 1995, 399 of these
428 were reported as dead. Therefore, the case-fatality rate is 93.2 (399 divided by 428, multiplied by 100). The case-fatality rates shown here may
be underestimates because of incomplete reporting of deaths. Reported deaths are not necessarily caused by HIV-related disease.
2Death totals include 352 adults/adolescents and 7 children known to have died, but whose dates of death are unknown.
 




Table 10. AIDS cases by year of diagnosis and definition category, diagnosed through 
June 1995, United States
 













Definition category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Pre-1987 definition 163,750 (73) 34,781 (52) 30,933 (39) 19,976 (30) 9,831 (25) 259,271 (54)





9,751 ( 4) 13,539 (20) 31,492 (39) 34,082 (52) 23,003 (59) 111,867 (23)
 
Pulmonary tuberculosis 1,616 1,276 1,891 1,480 528 6,791
Recurrent pneumonia 380 370 926 914 439 3,029






7,720 11,867 28,609 31,603 22,002 101,801
 




Persons who meet only the 1993 AIDS case definition and whose date of diagnosis is before January 1993 were diagnosed retrospectively. The sum
of diagnoses listed for the four conditions under the 1993 definition do not equal the 1993 definition total because some persons have more than one
















 percentage less than 14 in persons with laboratory confirmation of HIV
infection.
 
Table 11. Health care workers with documented and possible occupationally acquired 

















Dental worker, including dentist – 6
Embalmer/morgue technician – 2
Emergency medical technician/paramedic – 9
Health aide/attendant 1 11
Housekeeper/maintenance worker 1 7
Laboratory technician, clinical 15 14
Laboratory technician, nonclinical 3 0
Nurse 16 23
Physician, nonsurgical 6 10
Physician, surgical – 4
Respiratory therapist 1 2
Technician, dialysis 1 2
Technician, surgical 2 1
Technician/therapist, other than those listed above – 4






Health care workers are defined as those persons, including students and trainees, who have worked in a health care, clinical, or HIV laboratory set-








Health care workers who had documented HIV seroconversion after occupational exposure or had other laboratory evidence of occupational infec-
tion: 40 had percutaneous exposure, 4 had mucocutaneous exposure, 1 had both percutaneous and mucocutaneous exposures, and 1 had an
unknown route of exposure. Forty-one exposures were to blood from an HIV-infected person, 1 to visibly bloody fluid, 1 to an unspecified fluid, and 3




These health care workers have been investigated and are without identifiable behavioral or transfusion risks; each reported percutaneous or muco-
cutaneous occupational exposures to blood or body fluids, or laboratory solutions containing HIV, but HIV seroconversion specifically resulting from
an occupational exposure was not documented. 
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Table 12. Adult/adolescent AIDS cases by single and multiple exposure categories, reported
through June 1995, United States
 
AIDS cases
Exposure category No. (%)
Single mode of exposure
 
Men who have sex with men 235,025 (50)
Injecting drug use 97,574 (21)
Hemophilia/coagulation disorder 3,024 ( 1)

















Single mode of exposure subtotal 377,400 (80)
Multiple modes of exposure
 
Men who have sex with men; injecting drug use 27,164 ( 6)
Men who have sex with men; hemophilia/coagulation disorder 118 ( 0)
Men who have sex with men; heterosexual contact 5,814 ( 1)
Men who have sex with men; receipt of transfusion/transplant 3,009 ( 1)
Injecting drug use; hemophilia/coagulation disorder 155 ( 0)
Injecting drug use; heterosexual contact 18,841 ( 4)
Injecting drug use; receipt of transfusion/transplant 1,384 ( 0)
Hemophilia/coagulation disorder; heterosexual contact 55 ( 0)
Hemophilia/coagulation disorder; receipt of transfusion/transplant 766 ( 0)
Heterosexual contact; receipt of transfusion/transplant 1,086 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder 34 ( 0)
Men who have sex with men; injecting drug use; heterosexual contact 3,170 ( 1)
Men who have sex with men; injecting drug use; receipt of transfusion/transplant 509 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; heterosexual contact 12 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; receipt of transfusion/transplant 30 ( 0)
Men who have sex with men; heterosexual contact; receipt of transfusion/transplant 223 ( 0)
Injecting drug use; hemophilia/coagulation disorder; heterosexual contact 36 ( 0)
Injecting drug use; hemophilia/coagulation disorder; receipt of transfusion/transplant 29 ( 0)
Injecting drug use; heterosexual contact; receipt of transfusion/transplant 660 ( 0)
Hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 27 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; heterosexual contact; 7 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; receipt of transfusion/transplant 13 ( 0)
Men who have sex with men; injecting drug use; heterosexual contact; receipt of transfusion/transplant 125 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 4 ( 0)
Injecting drug use; hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 15 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; heterosexual contact; 
receipt of transfusion/transplant 2 ( 0)
 
Multiple modes of exposure subtotal 63,288 (13)













Ten adults developed AIDS after receiving tissue, organs, or artificial insemination from HIV-infected donors. Three of the 10 received tissue or
organs from a donor who was negative for HIV antibody at the time of donation. See 
 






See Table 11 and Figure 6 for a discussion of the “other” exposure category. “Other” also includes 25 persons who acquired HIV infection perinatally,
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Figure 1. Male adult/adolescent AIDS annual rates per 100,000 population, for cases reported
July 1994 through June 1995, United States
Figure 2. Female adult/adolescent AIDS annual rates per 100,000 population, for cases 
reported July 1994 through June 1995, United States
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Figure 3. Male adult/adolescent AIDS cases reported July 1994 through June 1995, 
United States
Figure 4. Female adult/adolescent AIDS cases reported July 1994 through June 1995, 
United States
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Figure 5. Pediatric AIDS cases reported July 1994 through June 1995, United States
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Figure 6. Investigations of adult/adolescent AIDS cases ever classified as risk not reported or






Excludes101 children under 13 years of age classified as “other/risk not reported or identified” in Table 3: 100 whose risk is not identified and 1 who












Investigations of these persons included patient interviews. Based on available information, these persons could not be reclassified into an exposure
category. This group includes persons possibly infected through heterosexual contact with a partner who is not known to be HIV infected or at high
risk for HIV infection; persons who may choose not to disclose high-risk information; and persons with possible occupational exposure. These 827
persons report heterosexual contact, sexually transmitted disease infections, non-injecting drug use, hepatitis infections, and occupational exposures




Fifty-two adult/adolescents are included in the “other” exposure category listed here and in Table 3, and were exposed to HIV-infected blood, body
fluids, or concentrated virus in health care, laboratory, or household settings, as supported by seroconversion, epidemiologic, and/or laboratory evi-








 1993;42:948-51. One person was infected following intentional self-inoculation of blood
from an HIV-infected person. Twenty-five persons acquired HIV infection perinatally and were diagnosed with AIDS after age 13.
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Table 13. Estimated AIDS-opportunistic illness incidence, by region of residence and year of









1990 1991 1992 1993 1994
 
Northeast 13,900 15,500 17,000 18,600 19,100
Midwest 4,600 5,500 6,300 6,300 6,500
South 15,000 17,400 20,400 21,000 23,500
West 10,600 12,200 13,000 12,500 13,200










Estimates are adjusted for delays in the reporting of AIDS cases, but not for incomplete reporting of cases. Estimates are rounded to the nearest 100.








The sum of the regional estimates may not equal the total annual estimates because of rounding.
 
Table 14. Estimated AIDS-opportunistic illness incidence, by race/ethnicity and year of 





Race/ethnicity 1990 1991 1992 1993 1994
 
White, not Hispanic 22,600 25,200 26,700 25,700 26,400
Black, not Hispanic 14,600 17,400 21,000 23,000 25,300
Hispanic 8,000 9,400 10,400 11,100 11,900
Asian/Pacific Islander 300 360 420 460 480










Estimates are adjusted for delays in the reporting of AIDS cases, but not for incomplete reporting of cases. Estimates of less than 200, 200 to 499,




The sum of race/ethnicity estimates may not equal the total annual estimates because of rounding. Totals include estimates of persons whose race/
ethnicity is unknown.
 
HIV/AIDS Surveillance Report 22 Vol. 7, No. 1
 
Table 15. Estimated AIDS-opportunistic illness incidence, by age group, sex, exposure 






exposure category 1990 1991 1992 1993 1994
 
Men who have sex with men 25,200 28,300 30,000 29,600 31,300
Injecting drug use 8,700 10,100 12,000 12,700 13,400
Men who have sex with men 
and inject drugs 3,200 3,500 3,800 3,600 3,500
Hemophilia/coagulation disorder 340 380 440 440 420
Heterosexual contact 1,100 1,500 2,100 2,600 3,100
Receipt of blood transfusion, 
blood components, or tissue 440 460 440 380 440
Risk not reported or identified 360 380 440 400 280





Injecting drug use 3,000 3,600 4,300 4,600 4,900
Hemophilia/coagulation disorder 10 20 10 20 20
Heterosexual contact 2,200 2,900 3,800 4,800 5,700
Receipt of blood transfusion, 
blood components, or tissue 320 320 320 340 400
Risk not reported or identified 120 190 200 150 110
Female subtotal 5,700 7,000 8,600 9,900 11,100
 















Estimates are adjusted for delays in the reporting of AIDS cases and anticipated redistribution of cases initially reported with no identified risk, but not
for incomplete reporting of cases. Adult/adolescent and total estimates of less than 200, 200 to 499, 500 to 999, and 1,000 or more are rounded to the
nearest 10, 20, 50, and 100, respectively. Pediatric estimates are rounded to the nearest 10. Opportunistic illness refers to AIDS-defining opportunis-




Estimates are based on cases diagnosed using the 1987 definition, adjusted for reporting delays.  The 1993 AIDS surveillance case definition




The sum of the exposure category estimates may not equal the subtotal and total annual estimates because of rounding.
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Table 16. HIV infection cases (not AIDS) by state, reported July 1994 through June 1995;  
and cumulative totals, by state and age group, through June 1995; from states 
with confidential HIV infection reporting
 
Cumulative totals
State of residence 






<13 years old Total
 
Alabama (Jan. 1988) 559 3,764 31 3,795
Arizona (Jan. 1987) 366 3,087 29 3,116
Arkansas (July 1989) 316 1,298 20 1,318





22 – 93 93
Idaho (June 1986) 50 343 3 346
Indiana (July 1988) 411 2,563 23 2,586
Louisiana (Feb. 1993) 1,161 3,714 42 3,756
Michigan (April 1992) 1,277 2,679 73 2,752
Minnesota (Oct. 1985) 309 2,093 22 2,115
Mississippi (Aug. 1988) 604 2,893 35 2,928
Missouri (Oct. 1987) 656 3,289 36 3,325
Nevada (Feb. 1992) 417 1,944 20 1,964
New Jersey (Jan. 1992) 4,259 10,221 306 10,527
North Carolina (Feb. 1990) 1,427 5,659 46 5,705
North Dakota (Jan. 1988) 7 59 – 59
Ohio (June 1990) 575 2,992 26 3,018
Oklahoma (June 1988) 176 1,540 9 1,549
South Carolina (Feb. 1986) 736 5,444 73 5,517
South Dakota (Jan. 1988) 21 148 5 153





145 – 189 189
Utah (April 1989) 89 775 5 780
Virginia (July 1989) 1,000 5,623 57 5,680
West Virginia (Jan. 1989) 96 359 2 361
Wisconsin (Nov. 1985) 252 1,845 23 1,868
Wyoming (June 1989) 9 57 – 57
 
Subtotal 16,476 70,626 1,231 71,857
 
Persons reported from states with confidential HIV 




490 1,694 26 1,720
 








Includes 347 persons reported from states with confidential HIV infection reporting, but whose state of residence is unknown. See Technical Notes.
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Table 17. Male adult/adolescent HIV infection cases (not AIDS) by exposure category and 
race/ethnicity, reported July 1994 through June 1995, and cumulative totals through

















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Men who have sex with men 2,615 (57) 15,135 (60) 1,715 (28) 7,883 (31) 265 (29) 1,132 (35)
Injecting drug use 559 (12) 2,274 ( 9) 1,403 (23) 5,646 (22) 306 (33) 964 (30)
Men who have sex with men
and inject drugs 283 ( 6) 2,103 ( 8) 210 ( 3) 1,272 ( 5) 27 ( 3) 203 ( 6)
Hemophilia/coagulation disorder 48 ( 1) 308 ( 1) 10 ( 0) 72 ( 0) 1 ( 0) 8 ( 0)
Heterosexual contact: 117 ( 3) 598 ( 2) 472 ( 8) 2,064 ( 8) 46 ( 5) 163 ( 5)
 
Sex with an injecting drug user 36 179 139 558 14 61
Sex with person with hemophilia – 4 2 5 – –
Sex with transfusion recipient  
with HIV infection – 16 7 30 – 2
Sex with HIV-infected person, 
risk not specified 81 399 324 1,471 32 100
 
Receipt of blood transfusion, 
blood components, or tissue 17 ( 0) 168 ( 1) 33 ( 1) 141 ( 1) 2 ( 0) 18 ( 1)




942 (21) 4,642 (18) 2,226 (37) 8,247 (33) 281 (30) 749 (23)
 








6,069 (100) 25,325 (100) 928 (100) 3,237 (100)
















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Men who have sex with men 16 (47) 74 (50) 17 (38) 150 (49) 4,675 (39) 24,611 (44)
Injecting drug use 3 ( 9) 14 (10) 10 (22) 51 (17) 2,296 (19) 9,028 (16)
Men who have sex with men 
and inject drugs 1 ( 3) 3 ( 2) 6 (13) 47 (15) 529 ( 4) 3,655 ( 7)
Hemophilia/coagulation disorder – – 3 ( 2) – – 4 ( 1) 61 ( 1) 400 ( 1)
Heterosexual contact: 1 ( 3) 6 ( 4) 2 ( 4) 10 ( 3) 644 ( 5) 2,869 ( 5)
 
Sex with an injecting drug user 1 3 1 2 193 811
Sex with person with hemophilia – – – – 2 9
Sex with transfusion recipient 
with HIV infection – – – – 7 48
Sex with HIV-infected person, 
risk not specified – 3 1 8 442 2,001
 
Receipt of blood transfusion, 
blood components, or tissue 1 ( 3) 3 ( 2) – – 3 ( 1) 53 ( 0) 339 ( 1)
Risk not reported or identified 12 (35) 44 (30) 10 (22) 44 (14) 3,637 (31) 14,761 (27)
 








For HIV infection cases (not AIDS), "risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who
have not been followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures




Includes 1,417 men whose race/ethnicity is unknown.
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Table 18. Female adult/adolescent HIV infection cases (not AIDS) by exposure category and
race/ethnicity, reported July 1994 through June 1995, and cumulative totals through

















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Injecting drug use 291 (28) 1,286 (30) 691 (22) 2,693 (25) 97 (26) 290 (29)
Hemophilia/coagulation disorder 1 ( 0) 7 ( 0) 1 ( 0) 7 ( 0) – – – –
Heterosexual contact: 346 (34) 1,595 (38) 891 (28) 3,660 (33) 113 (30) 382 (38)
 
Sex with an injecting drug user 120 614 276 1,188 49 178
Sex with a bisexual male 39 207 72 295 5 17
Sex with person with hemophilia 11 45 3 24 – 5
Sex with transfusion recipient 
with HIV-infection 4 23 6 27 – 3
Sex with HIV-infected person, 
risk not specified 172 706 534 2,126 59 179
 
Receipt of blood transfusion, 
blood components, or tissue 8 ( 1) 102 ( 2) 53 ( 2) 188 ( 2) 2 ( 1) 18 ( 2)




381 (37) 1,238 (29) 1,507 (48) 4,425 (40) 159 (43) 308 (31)
 
Total 1,027 (100) 4,229 (100) 3,143 (100) 10,973 (100) 371 (100) 998 (100)
















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Injecting drug use 2 (13) 6 (14) 7 (30) 40 (40) 1,094 (24) 4,340 (26)
Hemophilia/coagulation disorder – – – – – – – – 2 ( 0) 14 ( 0)
Heterosexual contact: 4 (27) 15 (35) 6 (26) 34 (34) 1,365 (29) 5,718 (34)
 
Sex with an injecting drug user 1 6 5 22 451 2,015
Sex with a bisexual male – – – 6 117 527
Sex with person with hemophilia – – – – 14 74
Sex with transfusion recipient 
with HIV infection – – – – 10 53
Sex with HIV-infected person,
 risk not specified 3 9 1 6 773 3,049
 
Receipt of blood transfusion, 
blood components, or tissue – – 1 ( 2) 1 ( 4) 1 ( 1) 64 ( 1) 316 ( 2)
Risk not reported or identified 9 (60) 21 (49) 9 (39) 26 (26) 2,120 (46) 6,253 (38)
 








For HIV infection cases (not AIDS), "risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who
have not been followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures




Includes 298 women whose race/ethnicity is unknown.
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Table 19. Pediatric HIV infection cases (not AIDS) by exposure category and race/ethnicity, 
reported July 1994 through June 1995, and cumulative totals through June 1995,

















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Hemophilia/coagulation disorder 10 ( 9) 68 (21) 3 ( 1) 22 ( 3) 4 ( 7) 9 ( 6)
Mother with/at risk for HIV infection: 91 (85) 221 (68) 225 (91) 646 (89) 45 (80) 137 (84)
 
Injecting drug use 19 50 65 165 15 35
Sex with injecting drug user 17 31 26 64 10 19
Sex with bisexual male 1 2 5 9 – 1
Sex with person with hemophilia – – 1 2 – –
Sex with transfusion recipient
with HIV infection 3 4 – 1 – –
Sex with HIV-infected person, 
risk not specified 15 29 36 78 5 14
Receipt of blood transfusion, 
blood components, or tissue 2 3 3 5 1 2
Has HIV infection, risk not specified 34 102 89 322 14 66
 
Receipt of blood transfusion, 
blood components, or tissue 1 ( 1) 18 ( 6) 2 ( 1) 5 ( 1) 3 ( 5) 5 ( 3)




5 ( 5) 19 ( 6) 18 ( 7) 49 ( 7) 4 ( 7) 12 ( 7)
 
Total 107 (100) 326 (100) 248 (100) 722 (100) 56 (100) 163 (100)
















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Hemophilia/coagulation disorder – – 1 (20) – – 2 (17) 18 ( 4) 105 ( 8)
Mother with/at risk for HIV infection: – – 1 (20) 2 (100) 8 (67) 370 (87) 1,026 (82)
 
Injecting drug use – – – 3 103 257
Sex with injecting drug user – – 2 2 55 116
Sex with bisexual male – 1 – – 6 13
Sex with person with hemophilia – – – 1 1 3
Sex with transfusion recipient 
with HIV infection – – – – 3 5
Sex with HIV-infected person, 
risk not specified – – – – 56 121
Receipt of blood transfusion, 
blood components, or tissue – – – – 6 10
Has HIV infection, risk not specified – – – 2 140 501
 
Receipt of blood transfusion, 
blood components, or tissue – – – – – – – – 8 ( 2) 30 ( 2)
Risk not reported or identified – – 3 (60) – – 2 (17) 27 ( 6) 96 ( 8)
 








For HIV infection cases (not AIDS), "risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who
have not been followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures




Includes 29 children whose race/ethnicity is unknown.
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Table 20. HIV infection cases (not AIDS) in adolescents and adults under age 25, by sex and
 exposure category, reported July 1994  through June 1995, and cumulative totals













Male exposure category No. (%) No. (%) No. (%) No. (%)
 
Men who have sex with men 108 (46) 583 (43) 728 (53) 4,235 (53)
Injecting drug use 5 ( 2) 70 ( 5) 77 ( 6) 478 ( 6)
Men who have sex with men 
and inject drugs 7 ( 3) 82 ( 6) 59 ( 4) 530 ( 7)
Hemophilia/coagulation disorder 14 ( 6) 93 ( 7) 14 ( 1) 89 ( 1)
Heterosexual contact: 9 ( 4) 90 ( 7) 84 ( 6) 428 ( 5)
 
Sex with an injecting drug user 1 17 24 93
Sex with person with hemophilia 1 2 – 1
Sex with transfusion recipient 
with HIV infection – 1 1 4
Sex with HIV-infected person, 
risk not specified 7 70 59 330
 
Receipt of blood transfusion, 
blood components, or tissue – – 11 ( 1) 4 ( 0) 38 ( 0)




91 (39) 434 (32) 401 (29) 2,179 (27)




Injecting drug use 11 ( 4) 99 ( 8) 83 (12) 436 (15)
Hemophilia/coagulation disorder – – – – – – 1 ( 0)
Heterosexual contact: 121 (40) 549 (43) 209 (30) 1,158 (39)
 
Sex with an injecting drug user 23 138 50 349
Sex with a bisexual male 6 41 22 128
Sex with person with hemophilia 2 10 7 26
Sex with transfusion recipient 
with HIV infection 2 4 2 11
Sex with HIV-infected person, 
risk not specified 88 356 128 644
 
Receipt of blood transfusion, 
blood components, or tissue 3 ( 1) 11 ( 1) 6 ( 1) 28 ( 1)
Risk not reported or identified 168 (55) 605 (48) 403 (57) 1,337 (45)














For HIV infection cases (not AIDS), "risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who
have not been followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures




Includes 4 persons whose sex is unknown.
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Table 21. HIV infection cases (not AIDS), by sex, age at diagnosis, and race/ethnicity, reported
















Age at diagnosis (years) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Under 5 116 ( 0) 321 ( 1) 63 ( 2) 2 ( 1) 3 ( 1) 511 ( 1)
5-12 74 ( 0) 59 ( 0) 19 ( 1) – – 2 ( 1) 161 ( 0)
13-19 558 ( 2) 712 ( 3) 51 ( 2) 4 ( 3) 8 ( 3) 1,363 ( 2)
20-24 3,744 (15) 3,546 (14) 415 (13) 26 (17) 59 (19) 7,977 (14)
25-29 6,579 (26) 5,477 (21) 833 (25) 41 (28) 95 (30) 13,353 (24)
30-34 6,041 (24) 5,703 (22) 813 (24) 31 (21) 69 (22) 12,998 (23)
35-39 3,975 (16) 4,759 (19) 571 (17) 18 (12) 40 (13) 9,607 (17)
40-44 2,199 ( 9) 2,831 (11) 322 (10) 14 ( 9) 22 ( 7) 5,521 (10)
45-49 1,100 ( 4) 1,180 ( 5) 137 ( 4) 7 ( 5) 8 ( 3) 2,516 ( 4)
50-54 546 ( 2) 607 ( 2) 46 ( 1) 3 ( 2) 5 ( 2) 1,243 ( 2)
55-59 239 ( 1) 254 ( 1) 21 ( 1) 2 ( 1) 2 ( 1) 532 ( 1)
60-64 131 ( 1) 133 ( 1) 17 ( 1) – – 1 ( 0) 287 ( 1)
65 or older 116 ( 0) 123 ( 0) 11 ( 0) 1 ( 1) – – 266 ( 0)
Male subtotal 25,418 (100) 25,705 (100) 3,319 (100) 149 (100) 314 (100) 56,335 (100)
 
Female
Age at diagnosis (years)
 
Under 5 115 ( 3) 291 ( 3) 65 ( 6) 2 ( 4) 6 ( 6) 491 ( 3)
5-12 21 ( 0) 51 ( 0) 16 ( 1) 1 ( 2) 1 ( 1) 93 ( 1)
13-19 252 ( 6) 930 ( 8) 52 ( 5) 1 ( 2) 10 ( 9) 1,264 ( 7)
20-24 816 (19) 1,924 (17) 149 (14) 10 (22) 19 (18) 2,960 (17)
25-29 1,047 (24) 2,462 (22) 271 (25) 16 (35) 18 (17) 3,888 (23)
30-34 931 (21) 2,406 (21) 255 (24) 9 (20) 20 (19) 3,689 (21)
35-39 590 (14) 1,678 (15) 122 (11) 1 ( 2) 22 (20) 2,452 (14)
40-44 264 ( 6) 883 ( 8) 80 ( 7) 3 ( 7) 9 ( 8) 1,264 ( 7)
45-49 158 ( 4) 332 ( 3) 35 ( 3) 2 ( 4) 2 ( 2) 546 ( 3)
50-54 53 ( 1) 148 ( 1) 15 ( 1) 1 ( 2) 1 ( 1) 222 ( 1)
55-59 45 ( 1) 100 ( 1) 13 ( 1) – – – – 160 ( 1)
60-64 22 ( 1) 50 ( 0) 5 ( 0) – – – – 79 ( 0)
65 or older 51 ( 1) 60 ( 1) 1 ( 0) – – – – 118 ( 1)
Female subtotal 4,365 (100) 11,315 (100) 1,079 (100) 46 (100) 108 (100) 17,226 (100)
Total3 29,784 37,022 4,398 195 423 73,577
1See Table 16 for states with confidential HIV infection reporting.
2Includes 1,430 males and 313 females whose race/ethnicity is unknown.
3Includes 16 persons whose sex is unknown.
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Table 22. Persons reported to be living with HIV infection (not AIDS) and with AIDS, by state
and age group, reported through June 19951



















Alabama (Jan. 1988) 3,673 31 3,704 1,431 18 1,449 5,104 49 5,153
Alaska – – – 140 1 141 140 1 141
Arizona (Jan. 1987) 2,768 25 2,793 1,343 8 1,351 4,111 33 4,144
Arkansas (July 1989) 1,279 20 1,299 849 15 864 2,128 35 2,163
California – – – 28,622 169 28,791 28,622 169 28,791
Colorado (Nov. 1985) 5,107 26 5,133 2,010 8 2,018 7,117 34 7,151
Connecticut (July 1992)4 – 86 86 3,016 75 3,091 3,016 161 3,177
Delaware – – – 585 4 589 585 4 589
District of Columbia – – – 3,086 62 3,148 3,086 62 3,148
Florida – – – 19,202 495 19,697 19,202 495 19,697
Georgia – – – 5,688 71 5,759 5,688 71 5,759
Hawaii – – – 583 4 587 583 4 587
Idaho (June 1986) 275 3 278 120 – 120 395 3 398
Illinois – – – 5,805 86 5,891 5,805 86 5,891
Indiana (July 1988) 2,475 22 2,497 1,477 14 1,491 3,952 36 3,988
Iowa – – – 345 4 349 345 4 349
Kansas – – – 569 3 572 569 3 572
Kentucky – – – 578 8 586 578 8 586
Louisiana (Feb. 1993) 3,585 40 3,625 2,820 45 2,865 6,405 85 6,490
Maine – – – 308 5 313 308 5 313
Maryland – – – 4,889 131 5,020 4,889 131 5,020
Massachusetts – – – 3,623 63 3,686 3,623 63 3,686
Michigan (April 1992) 2,382 62 2,444 2,706 28 2,734 5,088 90 5,178
Minnesota (Oct. 1985) 1,985 20 2,005 1,022 11 1,033 3,007 31 3,038
Mississippi (Aug. 1988) 2,820 35 2,855 882 19 901 3,702 54 3,756
Missouri (Oct. 1987) 3,203 36 3,239 2,580 15 2,595 5,783 51 5,834
Montana – – – 63 1 64 63 1 64
Nebraska – – – 247 3 250 247 3 250
Nevada (Feb. 1992) 1,849 19 1,868 996 11 1,007 2,845 30 2,875
New Hampshire – – – 273 3 276 273 3 276
New Jersey (Jan. 1992) 9,224 295 9,519 9,102 242 9,344 18,326 537 18,863
New Mexico – – – 466 2 468 466 2 468
New York – – – 26,240 671 26,911 26,240 671 26,911
North Carolina (Feb. 1990) 5,374 45 5,419 2,363 42 2,405 7,737 87 7,824
North Dakota (Jan. 1988) 52 – 52 26 – 26 78 – 78
Ohio (June 1990) 1,911 13 1,924 2,496 30 2,526 4,407 43 4,450
Oklahoma (June 1988) 1,493 9 1,502 946 5 951 2,439 14 2,453
Oregon – – – 1,260 4 1,264 1,260 4 1,264
Pennsylvania – – – 5,725 115 5,840 5,725 115 5,840
Rhode Island – – – 575 5 580 575 5 580
South Carolina (Feb. 1986) 5,189 71 5,260 2,248 23 2,271 7,437 94 7,531
South Dakota (Jan. 1988) 132 5 137 36 2 38 168 7 175
Tennessee (Jan. 1992) 2,918 37 2,955 2,044 14 2,058 4,962 51 5,013
Texas (Feb. 1994)4 – 181 181 13,174 129 13,303 13,174 310 13,484
Utah (April 1989) 760 5 765 458 6 464 1,218 11 1,229
Vermont – – – 102 1 103 102 1 103
Virginia (July 1989) 5,453 55 5,508 2,623 70 2,693 8,076 125 8,201
Washington – – – 2,618 11 2,629 2,618 11 2,629
West Virginia (Jan. 1989) 331 2 333 208 2 210 539 4 543
Wisconsin (Nov. 1985) 1,752 22 1,774 1,024 9 1,033 2,776 31 2,807
Wyoming (June 1989) 56 – 56 46 – 46 102 – 102
Subtotal 66,046 1,165 67,211 169,638 2,763 172,401 235,684 3,928 239,612
Guam – – – 4 – 4 4 – 4
Pacific Islands, U.S. – – – – – – – – –
Puerto Rico – – – 5,851 153 6,004 5,851 153 6,004
Virgin Islands, U.S. – – – 134 7 141 134 7 141
Total 66,046 1,165 67,211 175,627 2,923 178,550 241,673 4,088 245,761
1Persons reported with vital status "alive" as of the last update.
2Includes only persons reported from states with confidential HIV reporting. Excludes 1,553 adults/adolescents and 26 children reported from states
with confidential HIV infection reporting whose state of residence is unknown or are residents of other states.
3Includes 225 adults/adolescents and 2 children whose state of residence is unknown.
4Connecticut and Texas have confidential HIV infection reporting for pediatric cases only.
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Surveillance of AIDS 
All 50 states, the District of Columbia, U.S. depen-
dencies and possessions, and independent nations in
free association with the United States1 report AIDS
cases to CDC using a uniform surveillance case defi-
nition and case report form. The original definition was
modified in 1985 (MMWR 1985;34:373-75) and 1987
(MMWR 1987;36[suppl no. 1S]:1S-15S). The case
definition for adults and adolescents was modified
again in 1993 (MMWR 1992;41[no. RR-17]:1-19; see
also MMWR 1995;44:160-61,64-7). The revisions
incorporated a broader range of AIDS-indicator dis-
eases and conditions and used HIV diagnostic tests
to improve the sensitivity and specificity of the defini-
tion. The laboratory and diagnostic criteria for the
1987 pediatric case definition (MMWR 1987;36:
225-30,235) were updated in 1994 (MMWR 1994;
43[no. RR-12]:1-19).
For persons with laboratory-confirmed HIV infec-
tion, the 1987 revision incorporated HIV encephalopa-
thy, wasting syndrome, and other indicator diseases
that are diagnosed presumptively (i.e., without confir-
matory laboratory evidence of the opportunistic dis-
ease). In addition to the 23 clinical conditions in the
1987 definition, the 1993 case definition for adults and
adolescents includes HIV-infected persons with CD4+
T-lymphocyte counts of less than 200 cells/µL or a
CD4+ percentage of less than 14, and persons diag-
nosed with pulmonary tuberculosis, recurrent pneu-
monia, and invasive cervical cancer. All conditions
added to the 1993 definition require laboratory confir-
mation of HIV infection. Persons who meet the criteria
for more than one definition category are classified
hierarchically in the following order: pre-1987, 1987,
and 1993. Persons in the 1993 definition category
meet only the 1993 definition. 
The pediatric case definition incorporates the
revised 1994 pediatric classification system for evi-
dence of HIV infection. Children with their first positive
results on Western blot or HIV detection tests before
October 1994 were categorized based on the 1987
classification system.  Those tested during or after
October 1994 are categorized under the revised 1994
pediatric classification system.  For children of any
1 Included among the dependencies, possessions, and independent
nations are Puerto Rico, the U.S. Virgin Islands, Guam, American
Samoa, the Republic of Palau, the Republic of the Marshall Islands,
the Commonwealth of the Northern Mariana Islands, and the Fed-
erated States of Micronesia. The latter 5 comprise the category
“Pacific Islands, U.S.” listed in Tables 1 and 22.
age with an AIDS-defining condition that requires evi-
dence of HIV infection, a single positive HIV-detection
test (i.e., HIV culture, HIV PCR, or HIV antigen [p24])
is sufficient for a reportable AIDS diagnosis if the diag-
nosis is confirmed by a clinician.  The 1994 pediatric
definitions for HIV encephalopathy and HIV wasting
syndrome reflect increased knowledge of these condi-
tions in children, and replace the 1987 definitions.
Although completeness of reporting of diagnosed
AIDS cases to state and local health departments var-
ies by geographic region and patient population, stud-
ies conducted by state and local health departments
indicate that reporting of AIDS cases in most areas of
the United States is more than 85 percent complete (J
Acquir Immune Def Syndr, 1992;5:257-64 and Am J
Public Health 1992;82:1495-99). In addition, multiple
routes of exposure, opportunistic diseases diagnosed
after the initial AIDS case report was submitted to
CDC, and vital status may not be determined or
reported for all cases.
Included in this report are persons known to be
infected with human immunodeficiency virus type 2
(HIV-2). See MMWR 1995;44:603-06.
Surveillance of HIV infection (not AIDS) 
Through December 31, 1994, 25 states had laws or
regulations requiring confidential reporting by name of
all persons with confirmed HIV infection, in addition to
reporting of persons with AIDS. Two other states,
Connecticut and Texas, required reporting by name of
HIV infection only for children less than 13 years of
age. These states initiated reporting at various times
after the development of serum HIV-antibody tests in
1985. Before 1991, surveillance of HIV infection was
not standardized and reporting of HIV infections was
based primarily on passive surveillance. Conse-
quently, many cases reported before 1991 do not
have complete information. Since then, CDC has
assisted states in conducting active surveillance of
HIV infection using standardized report forms and
software. However, collection of demographic and risk
information still varies greatly among states. 
HIV infection data should be interpreted with cau-
tion. HIV surveillance reports are not representative of
all persons with HIV infection. Because many
HIV-reporting states also offer anonymous HIV test-
ing, confidential HIV infection reports are not repre-
sentative of all persons being tested in these areas.
Furthermore, many factors may influence testing pat-
Technical notes
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terns, including the extent that testing is targeted or
routinely offered to specific groups and the availability
and access to medical care and testing services.
These data provide a minimum estimate of the num-
ber of persons known to be HIV infected in states with
confidential HIV infection reporting.
For this report, persons greater than 18 months of
age were considered HIV infected if they had at least
one positive Western blot or positive detection test
(culture, antigen, or other detection test) or had a
diagnosis of HIV infection documented by a physician.
Before October 1994, children less than 15 months of
age were considered HIV infected if they met the defi-
nition stated in the 1987 pediatric classification sys-
tem for HIV infection (MMWR 1987;36:225-30,235).
Beginning October 1994, children less than 18
months of age are considered HIV infected if they
meet the definition stated in the 1994 pediatric classi-
fication system for HIV infection (MMWR 1994;43[no.
RR-12]:1-10). This report also includes children who
were diagnosed as HIV infected by a physician.
Although many states monitor reports of children born
to infected mothers, only those with documented diag-
nosis of HIV infection are included in this report. 
Because states initiated reporting on different
dates, the length of time reporting has been in place
will influence the number of HIV infection cases
reported. For example, data presented for a given
annual period may include cases reported during only
a portion of the year. Prior to statewide HIV reporting,
some states collected reports of HIV infection in
selected populations. Therefore, these states have
reports prior to initiation of statewide confidential
reporting.
Over time, persons with HIV infection will be diag-
nosed and reported with AIDS. HIV infection cases
later reported with AIDS are deleted from the HIV
infection tables and added to the AIDS tables. Per-
sons with HIV infection may be tested at any point in
the clinical spectrum of disease, therefore the time
between diagnosis of HIV infection and AIDS will vary.
In addition, because surveillance practices differ,
reporting and updating of clinical and vital status of
cases vary among states. 
Included in this report are persons known to be
infected with human immunodeficiency virus type 2
(HIV-2). See MMWR 1995;44:603-06.
Tabulation and presentation of HIV infection
and AIDS data
Data in this report are provisional. Each issue of
this report includes information received by CDC
through the last day of the reporting period. AIDS data
are tabulated by date of report to CDC unless other-
wise noted. Data for U.S. dependencies and posses-
sions and for associated independent nations are
included in the totals. 
Age group tabulations are based on the person's
age at first documented positive HIV-antibody test
result for HIV infection cases, and age at diagnosis of
AIDS for AIDS cases. Adult/adolescent cases include
persons 13 years of age and older; pediatric cases
include children under 13 years of age. Age group
tabulations for AIDS cases in Table 14 (year-end edi-
tion only) are based on age at death.
Tabulations of persons living with HIV and AIDS
(Table 22), include persons whose vital status was
“alive” as of the last update; persons whose vital sta-
tus is missing or unknown are not included. Caution
should be used in interpreting these data because
states vary in the frequency with which they review
the vital status of persons reported with HIV infection
and AIDS.  In addition, some cases may be lost to
follow-up.
Table 12 (year-end edition only) tabulates
AIDS-indicator conditions reported during the last
year. These data are known to underreport
AIDS-indicator conditions and should be interpreted
with caution. Reported conditions overrepresent initial
AIDS-indicator illness because follow-up for subse-
quent indicator diseases is resource intensive and
has not been systematic or standardized in most
health departments.  The 1993 AIDS surveillance
case definition for adults and adolescents added
reporting of HIV-infected persons with severe
HIV-related immunosuppression (CD+ T-lymphocyte
count of less than 200 µL or less than 14 percent).
Since implementation of the 1993 definition, approxi-
mately half of all cases were reported based only on
immunologic criteria; consequently, reporting of AIDS
cases based on AIDS-defining opportunistic infections
has decreased (see AIDS 1994;8:1489-93).
Table 2 lists AIDS case counts for each metropoli-
tan area with 500,000 or more population.  AIDS case
counts for metropolitan areas with 50,000 to 500,000
population are reported as a combined subtotal. On
December 31, 1992, the Office of Management and
Budget announced new Metropolitan Statistical Area
(MSA) definitions, which reflect changes in the U.S.
population as determined by the 1990 census. These
definitions were updated most recently on July 1,
1994. The cities and counties which compose each
metropolitan area listed in Table 2 are provided in the
publication “Metropolitan Areas as of June 30, 1995”
(available by calling the National Technical Informa-
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tion Service, 1-703-487-4650, and ordering accession
no. PB95-208880). Standards for defining central and
outlying counties of metropolitan areas were pub-
lished in the Federal Register (see FR 1990;55:
12154-60).
The metropolitan areas definitions are the MSAs
for all areas except the 6 New England states. For
these states, the New England County Metropolitan
Areas (NECMA) are used. Metropolitan areas are
named for a central city in the MSA or NECMA, may
include several cities and counties, and may cross
state boundaries. For example, AIDS cases and
annual rates presented for the District of Columbia in
Table 1 include only persons residing within the geo-
graphic boundaries of the District. AIDS cases and
annual rates for Washington, D.C., in Table 2 include
persons residing within the several counties in the
metropolitan area, including counties in Maryland, Vir-
ginia, and West Virginia. State or metropolitan area
data tabulations are based on the person's residence
at first positive HIV-antibody test result for HIV infec-
tion cases and residence at diagnosis of the first
AIDS-indicator condition(s) for AIDS cases.
Estimated AIDS-opportunistic illness
In 1993, the AIDS surveillance case definition was
expanded to include a laboratory measure of severe
immunosuppression (CD4+ T-lymphocyte count of
less than 200 cells/µL or a percent of total lympho-
cytes less than 14) and three additional clinical condi-
tions (pulmonary tuberculosis, recurrent pneumonia,
and invasive cervical cancer). Before 1993, the sur-
veillance definition included only opportunistic ill-
nesses, and trends in the incidence of AIDS were
evaluated by examining the number of AIDS opportu-
nistic illnesses (AIDS-OIs) diagnosed per year or
quarter (adjusted for reporting delays). Because most
HIV-infected persons become severely immunosup-
pressed before the onset of AIDS-OIs, the addition of
the CD4+ criteria has temporarily distorted observed
trends in AIDS incidence. To examine trends over
time, an additional adjustment is required to estimate
when an AIDS-OI will develop in persons who were
reported based on the CD4+ criteria.  CDC has devel-
oped a procedure to estimate the incidence of
AIDS-OIs among persons reported with AIDS based
on the CD4+ criteria.  Estimates of trends in AIDS-OIs
are displayed in Tables 13, 14, and 15.
The estimated AIDS-OI incidence is the sum of inci-
dence in two groups.  The first group is persons
reported to AIDS surveillance with AIDS-OIs.  Inci-
dence in this group is estimated by adjusting reported
cases for delays in case reporting.
The second group is persons reported with AIDS
based on a CD4+ count or percent.  Most of these
persons will eventually have an AIDS-OI diagnosed.
CDC has estimated the number of persons who had
or will have an AIDS-OI diagnosed after the date of
the reported CD4+ count or percent, by month of
AIDS-OI diagnosis. To do this, CDC used data from
the Adult Spectrum of Disease Project (see JAMA
1992;267:1798-1805) to estimate the probability dis-
tribution of the time interval between a CD4+ count in
a particular range (e.g., 0 to 29 cells/µL, 30 to 59 cells/
µL, etc.) and the diagnosis of an AIDS-OI. This proba-
bility distribution is the proportion of persons with a
CD4+ count in a given range who will have an
AIDS-OI diagnosed 1 month, 2 months, etc., after the
reported CD4+ count. The expected number of per-
sons with an AIDS-OI diagnosed in each later month
among persons whose CD4+ count was in a particular
range during a given month is the product of the num-
ber of these persons and the proportion expected to
have an AIDS-OI diagnosed in this later month. The
estimate of the number of AIDS-OI diagnoses in a
particular month among persons reported with AIDS
based on the CD4+ criteria is the sum, over all combi-
nations of CD4+ ranges and previous months, of the
number of persons expected to be diagnosed with an
AIDS-OI in the month for which the estimate is made.
There is uncertainty in these estimates of AIDS-OI
incidence.  Some uncertainty is the result of the need
to adjust for delays in reporting of AIDS cases.  There
is additional uncertainty because some persons
reported with AIDS based on the CD4+ criteria die
before an AIDS-OI is diagnosed and hence should not
contribute to the AIDS-OI incidence estimate.  Other
persons reported with AIDS based on the CD4+ crite-
ria have an unreported AIDS-OI diagnosis by the date
of the CD4+ determination; the estimation procedure
counts their contribution to AIDS-OI incidence later
than it should.  However, preliminary analyses show
that these two sources of bias change estimated
AIDS-OI incidence by only a few percentage points.
Reporting delays were estimated by a maximum
likelihood statistical procedure, taking into account
possible differences in reporting delays among expo-
sure, geographic, racial/ethnic, age, and sex catego-
ries, but assuming that reporting delays within these
groups have not changed over time (see Lecture
Notes in Biomathematics 1989;83:58-88).
The regions of residence included in Table 13 are
defined as follows. Northeast: Connecticut, Maine,
Massachusetts, New Hampshire, New Jersey, New
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York, Pennsylvania, Rhode Island, and Vermont; Mid-
west: Indiana, Illinois, Iowa, Kansas, Michigan, Min-
nesota, Missouri, Nebraska, North Dakota, Ohio,
South Dakota, and Wisconsin; South: Alabama,
Arkansas, Delaware, District of Columbia, Florida,
Georgia, Kentucky, Louisiana, Maryland, Mississippi,
North Carolina, Oklahoma, South Carolina, Tennes-
see, Texas, Virginia, and West Virginia; West: Alaska,
Arizona, California, Colorado, Idaho, Hawaii, Mon-
tana, Nevada, New Mexico, Oregon, Utah, Washing-
ton, and Wyoming; Territories: Guam, Puerto Rico,
the U.S. Virgin Islands, and the U.S. Pacific Islands
listed on page 30.
Exposure categories
For surveillance purposes, HIV infection cases and
AIDS cases are counted only once in a hierarchy of
exposure categories. Persons with more than one
reported mode of exposure to HIV are classified in the
exposure category listed first in the hierarchy, except
for men with both a history of sexual contact with
other men and injecting drug use. They make up a
separate exposure category. 
“Men who have sex with men” cases include men
who report sexual contact with other men (i.e., homo-
sexual contact) and men who report sexual contact
with both men and women (i.e., bisexual contact).
“Heterosexual contact” cases are in persons who
report specific heterosexual contact with a person
with, or at increased risk for, HIV infection (e.g., an
injecting drug user).
Adults/adolescents born, or who had sex with
someone born, in a country where heterosexual trans-
mission was believed to be the predominant mode of
HIV transmission (formerly classified as Pattern-II
countries by the World Health Organization) are no
longer classified as having heterosexually acquired
AIDS. Similar to case reports for other persons who
are reported without behavioral or transfusion risks for
HIV, these reports are now classified (in the absence
of other risk information which would classify them
into another exposure category) as “no risk reported
or identified” (see MMWR 1994;43:155-60). Children
whose mother was born, or whose mother had sex
with someone born, in a Pattern-II country are now
classified (in the absence of other risk information
which would classify them into another exposure cate-
gory) as “Mother with/at risk for HIV infection: has HIV
infection, risk not specified.”
“No risk reported or identified” cases are in persons
with no reported history of exposure to HIV through
any of the routes listed in the hierarchy of exposure
categories. Risk not identified cases include persons
who are currently under investigation by local health
department officials; persons whose exposure history
is incomplete because they died, declined to be inter-
viewed, or were lost to follow-up; and persons who
were interviewed or for whom other follow-up informa-
tion was available and no exposure mode was identi-
fied. Persons who have an exposure mode identified
at the time of follow-up are reclassified into the appro-
priate exposure category. In general, investigations
and follow up for modes of exposure by state health
departments are conducted routinely for persons
reported with AIDS and as resources allow for those
reported with HIV infection. Therefore, the percentage
of HIV infected persons with risk not reported or iden-
tified is substantially higher than for those reported
with AIDS.  As HIV infected persons with risk not
reported or identified are diagnosed and reported with
AIDS, they are assigned higher priority for follow-up to
determine the mode(s) of exposure.
Rates
Rates are calculated on a 12-month basis per
100,000 population for AIDS cases only. Rates are
not calculated for HIV infection reports because case
counts for HIV infection are believed to be less com-
plete than AIDS case counts. Population denomina-
tors for computing AIDS rates for the 50 states and
the District of Columbia are based on official
post-census estimates from the U.S. Bureau of Cen-
sus. Denominators for U.S. dependencies and pos-
sessions are linear extrapolations of official 1980 and
1990 census counts. Each 12-month rate is the num-
ber of cases reported during the 12-month period,
divided by the 1994 or 1995 population,  multiplied by
100,000. The denominators for computing
race-specific rates (Table 10, year-end edition only)
are based on 1990 census projections published in
U.S. Bureau of Census publication P25-1104, “Popu-
lation Projections of the United States, by Age, Sex,
Race, and Hispanic Origin: 1993 to 2050.”
Race-specific rates are the number of cases reported
for a particular racial/ethnic group during the preced-
ing 12-month period divided by the projected popula-
tion for that race/ethnicity, multiplied by 100,000.
Case-fatality rates are calculated for each half-year
by date of diagnosis of AIDS. Each 6-month
case-fatality rate is the number of deaths ever
reported among cases diagnosed in that period
(regardless of the year of death), divided by the num-
HIV/AIDS Surveillance Report 34 Vol. 7, No. 1
ber of total cases diagnosed in that period, multiplied
by 100. Reported deaths are not necessarily caused
by HIV-related disease. Caution should be used in
interpreting case-fatality rates because reporting of
deaths is incomplete (see Am J Public Health 1992;
82:1500-05 and Am J Public Health 1990; 80:
1080-86).
Reporting delays
Reporting delays (time between diagnosis of HIV
infection or AIDS and report to CDC) vary widely
among exposure, geographic, racial/ethnic, age and
sex categories, and have been as long as several
years for some AIDS cases. About 50 percent of all
AIDS cases were reported to CDC within 3 months of
diagnosis, with about 20 percent being reported more
than one year after diagnosis. Reporting delay for HIV
infection cases is being evaluated. 
